User:nicolespzl832356

Emibetuzumab, formerly known as LY2875358, represents a novel treatment strategy in oncology, specifically targeting the HGFR tyrosine kinase. This humanized antibody functions by selectively

https://www.targetmol.com/compound/emibetuzumab